ID M28583; SV 1; linear; mRNA; STD; HUM; 1033 BP.
XX
AC M28583;
XX
DT 02-FEB-1990 (Rel. 22, Created)
DT 17-JUN-2008 (Rel. 96, Last updated, Version 20)
XX
DE Human (clone FJ0-1) MHC class II DR subtype Dw2 mRNA, complete cds,
DE haplotype HLA-DR2.
XX
KW cell surface glycoprotein; class II gene; integral membrane glycoprotein;
KW lymphocyte antigen; major histocompatibility complex.
XX
OS Homo sapiens (human)
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC Homo.
XX
RN [1]
RP 1-1033
RX PUBMED; 3571980.
RA Wu S.K., Yabe T., Madden M., Saunders T.L., Bach F.H.;
RT "cDNA cloning and sequencing reveals that the electrophoretically constant
RT DR beta 2 molecules, as well as the variable DR beta 1 molecules, from
RT HLA-DR2 subtypes have different amino acid sequences including a
RT hypervariable region for a functionally important epitope";
RL J. Immunol. 138(9):2953-2959(1987).
XX
DR MD5; 654716b2dbb1b63a24b9e183bd2afff0.
DR IMGT/HLA; HLA-DRB1*16:01:01; HLA00876.
XX
CC On Sep 21, 1994 this sequence version replaced gi:341964.
XX
FH Key Location/Qualifiers
FH
FT source 1..1033
FT /organism="Homo sapiens"
FT /map="6p21.3"
FT /mol_type="mRNA"
FT /haplotype="HLA-DR2"
FT /cell_line="Epstein-Barr virus transformed lymphoblastoid
FT cell line LCL"
FT /tissue_lib="of Betuel"
FT /db_xref="taxon:9606"
FT sig_peptide 40..126
FT /gene="HLA-DRB2"
FT /note="G00-120-643"
FT CDS 40..840
FT /codon_start=1
FT /gene="HLA-DRB2"
FT /product="MHC class II DR-beta"
FT /db_xref="GOA:Q29974"
FT /db_xref="H-InvDB:HIT000195243.14"
FT /db_xref="HGNC:HGNC:4948"
FT /db_xref="InterPro:IPR000353"
FT /db_xref="InterPro:IPR003006"
FT /db_xref="InterPro:IPR003597"
FT /db_xref="InterPro:IPR007110"
FT /db_xref="InterPro:IPR011162"
FT /db_xref="InterPro:IPR013783"
FT /db_xref="InterPro:IPR014745"
FT /db_xref="InterPro:IPR036179"
FT /db_xref="UniProtKB/Swiss-Prot:Q29974"
FT /protein_id="AAA59680.1"
FT /translation="MVCLKLPGGSCMTALTVTLMVLSSPLALAGDTRPRFLWQPKRECH
FT FFNGTERVRFLDRYFYNQEESVRFDSDVGEYRAVTELGRPDAEYWNSQKDFLEDRRAAV
FT DTYCRHNYGVGESFTVQRRVQPKVTVYPSKTQPLQHHNLLVCSVSGFYPGSIEVRWFLN
FT GQEEKAGMVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTSPLTVEWRARSE
FT SAQSKMLSGVGGFVLGLLFLGAGLFIYFRNQKGHSGLQPTGFLS"
FT mat_peptide 127..837
FT /gene="HLA-DRB2"
FT /product="MHC class II DR-beta"
FT /note="G00-120-643"
XX
SQ Sequence 1033 BP; 217 A; 278 C; 309 G; 229 T; 0 other;
cctgcttctc tggcccctgg tcctgtcctg ttctccagca tggtgtgtct gaagctccct 60
ggaggctcct gcatgacagc gctgacagtg acactgatgg tgctgagctc cccactggct 120
ttggctgggg acacccgacc acgtttcctg tggcagccta agagggagtg tcatttcttc 180
aatgggacgg agcgggtgcg gttcctggac agatacttct ataaccagga ggagtccgtg 240
cgcttcgaca gcgacgtggg ggagtaccgg gcggtgacgg agctggggcg gcctgacgct 300
gagtactgga acagccagaa ggacttcctg gaagacaggc gcgccgcggt ggacacctac 360
tgcagacaca actacggggt tggtgagagc ttcacagtgc agcggcgagt ccaacctaag 420
gtgactgtat atccttcaaa gacccagccc ctgcagcacc acaacctcct ggtctgctct 480
gtgagtggtt tctatccagg cagcattgaa gtcaggtggt tcctgaacgg ccaggaagag 540
aaggctggga tggtgtccac aggcctgatc cagaatggag actggacctt ccagaccctg 600
gtgatgctgg aaacagttcc tcgaagtgga gaggtttaca cctgccaagt ggagcaccca 660
agcgtgacaa gccctctcac agtggaatgg agagcacggt ctgaatctgc acagagcaag 720
atgctgagtg gagtcggggg ctttgtgctg ggcctgctct tccttggggc cgggctgttc 780
atctacttca ggaatcagaa aggacactct ggacttcagc caacaggatt cctgagctga 840
aatgcagatg accacattca aggaagaact ttctgccccg gctttgcagg atgaaaagct 900
ttcctgcttg gcagttattc ttccacaaga gagggctttc tcaggacctg gttgctactg 960
gttcggcaac tgcagaaaat gtcctccctt gtggcttcct cagctcctgc ccttggcctg 1020
aagtcccagc att 1033
//